β-TrCP1 degradation is a novel action mechanism of PI3K/mTORC2 inhibitors in triple-negative breast cancer cells.
2015-02-26

2015. Yi YW, Kang HJ, Bae EJ, Oh S, Soeng YS, Bae I. Experimental & Molecular Medicine. 47: e143.